文献速递肝病

酒精相关性肝病:酒精使用障碍的整合管理

Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder.
PubMed 文献 · Clin Gastroenterol Hepatol · 2023-02-27

酒精相关性肝病(ALD)是全球许多地区肝硬化和肝相关死亡最常见的原因,约75%的肝硬化患者直到被转诊至急诊科才知晓自身疾病。ALD患者同时存在肝病和酒精使用障碍(AUD)两个主要问题,仅关注肝病常导致治疗失败。由肝病科医生和成瘾专家提供的整合照护模式是有效方法,但尚未广泛可用。AUD有多种药物和非药物治疗;重症酒精性肝炎(AH)管理取得进展,通过更好理解治疗应答概念、改进生存预测及早期肝移植的出现改善了生存。新出现的概念是,将重症ALD患者列入移植名单可根据肝功能障碍的严重程度和演变以及患者的成瘾特征来调整戒酒持续时间。

要点

  • 约75%的肝硬化患者直到被转诊至急诊科才知晓自身疾病,需要创新的无创筛查方法以早期诊断肝纤维化。
  • ALD患者同时存在肝病和酒精使用障碍两个主要问题,仅关注肝病常导致治疗失败,因为肝功能短暂改善在患者恢复饮酒后迅速逆转。
  • 由肝病科医生和成瘾专家提供的整合照护模式是有效方法,但尚未广泛可用;AUD有多种药物和非药物治疗。

核心结论

  • ALD患者需要同时管理肝病和酒精使用障碍,整合照护模式是有效方法但尚未广泛可用。
  • 重症AH管理通过更好理解治疗应答概念、改进生存预测及早期肝移植的出现改善了生存。
  • 新出现的概念是,将重症ALD患者列入移植名单可根据肝功能障碍的严重程度和演变以及患者的成瘾特征来调整戒酒持续时间。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 约75%的肝硬化患者直到被转诊至急诊科才知晓自身疾病。
  • 仅关注肝病常导致治疗失败,因为肝功能短暂改善在患者恢复饮酒后迅速逆转。
  • AUD有多种药物和非药物治疗;重症AH管理取得进展,通过更好理解治疗应答概念、改进生存预测及早期肝移植的出现改善了生存。

关键数值与推荐

  • 原文未报告具体推荐条款或数值标准。

临床怎么用

  • 原文未据此给出具体推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alcohol-associated liver disease (ALD) is the most common cause of cirrhosis and liver-related mortality in many regions worldwide. Around 75% of patients with cirrhosis are unaware of their disease until they are referred to the emergency department. An innovative, noninvasive screening approach is required for an earlier diagnosis of liver fibrosis. In patients with ALD the physician is inevitably dealing with 2 major disorders: the liver disease itself and the alcohol use disorder (AUD). Focus only on the liver disease will inevitably lead to failure because transient improvements in liver function are rapidly overturned if the patient returns to alcohol consumption. For this reason, integrated models of care provided by hepatologists and addiction specialists are an effective approach, which are, however, not widely available. There are multiple pharmacologic and non-pharmacologic therapies for AUD. Progress has recently been made in the management of patients with severe AH who have improved survival through better understanding of the concept of response to medical treatment, improved survival prediction, and the advent of early liver transplantation. The emerging concept is that listing for transplantation a patient with severe ALD could lead to adjusting the duration of abstinence according to the severity and evolution of liver dysfunction and the patient's addictive profile.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Arab JP, Addolorato G, Mathurin P, et al. Alcohol-Associated Liver Disease: Integrated Management With Alcohol Use Disorder. Clin Gastroenterol Hepatol. 2023. PMID: 36858144. doi:10.1016/j.cgh.2023.02.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。